Ipamorelin
Lyophilized research reference material. Released with a per-lot Certificate of Analysis. For laboratory research use only.
- All products currently listed on this site are for research purposes ONLY.
- All products sold on this website are intended for research and identification purposes only.
- These products are not intended for human dosing, injections, or ingestion.
- Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption.
Research background
Ipamorelin is a synthetic pentapeptide and selective agonist of the growth-hormone secretagogue receptor (the ghrelin receptor). It was characterized as the first GHS to stimulate growth-hormone release with high selectivity and without the elevations in cortisol, prolactin, or ACTH seen with earlier secretagogues.
The foundational pharmacology is well documented in preclinical work; ipamorelin has not advanced to an approved indication.
Summary of published scientific literature provided for laboratory research reference only. It is not a claim of safety, efficacy, or suitability for any use, and does not describe or recommend any human or veterinary use.
Selected references
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998;139(5):552-561.
- Gobburu JV, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers. Pharmaceutical Research. 1999;16(9):1412-1416.
- Johansen PB, et al. The GH secretagogue ipamorelin and bone. Growth Hormone & IGF Research. 1999;9(2):106-113.
Trademarks & attribution
Ipamorelin (NNC 26-0161) originated from Novo Nordisk research and has no approved trademarked drug product. Catalyst Research Labs is not affiliated with Novo Nordisk. Supplied as reference material only.
-
PeptidesRESEARCH USE ONLY COA 2–8°C
